Results 111 to 120 of about 3,743 (224)

Paradoxical Effects of Atorvastatin on Renal Tubular Cells An Experimental Investigation [PDF]

, 2015
Introduction. Atorvastatin has antioxidant activity and has been reported to increase blood antioxidant capacity. This study aimed to evaluate the effect of different doses of atorvastatin on gentamicin-induced kidney injury. Materials and Methods.
Ahmadi, Ali., Baradaran, Azar., Hasanpour, Zahra., Nasri, Hamid., Nasri, Parto., Nematbakhsh, Mehdi., Rafieian-Kopaei, Mahmoud.   +6 more
core  

Volume 16

Journal of Diabetes Investigation, Volume 16, Issue 12, Page 2260-2284, December 2025.
wiley   +1 more source

Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer [PDF]

, 2010
Noriyuki Masuda, Shunichi Negoro, Frederick Hausheer, Kazuhiko Nakagawa, Kaoru Matsui, Shinzoh Kudoh, Koji Takeda, Nobuyuki Yamamoto, Naruo Yoshimura, Yasuo Ohashi, Masahiro Fukuoka   +10 more
core   +1 more source

Can Dexrazoxane and Carvedilol prevent Doxorubicin-induced nephrotoxicity?

Current Issues in Pharmacy and Medical Sciences
Doxorubicin (DOX) is a cytostatic drug with a broad spectrum of anticancer activity that has been used in oncology for over 50 years. Among many adverse effects in humans, the most dangerous is late dilated cardiomyopathy, which appears even years after ...
Szponar Jaroslaw, Gorska Agnieszka, Ostrowska-Lesko Marta, Wielgomas Bartosz, Mandziuk Slawomir   +4 more
doaj   +1 more source

Endothelial KLF11 as a Nephroprotectant in AKI

Kidney360, 2022
Gelare Ghajar-Rahimi, Anupam Agarwal
openaire   +2 more sources

Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease

International Journal of Nephrology and Renovascular Disease
Kavya Rajan,1 Arjun Krishen Jutley,2 Michael W Holliday Jr,3,4 Sankar D Navaneethan3– 5 1Innovation Academy High School, Alpharetta, GA, USA; 2Tomball Memorial High School, Houston, TX, USA; 3Selzman Institute for Kidney Health, Section of Nephrology ...
Rajan K, Jutley AK, Holliday MW Jr, Navaneethan SD   +3 more
doaj  

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2015
Abassi, Zaid, Armaly, Zaher
openaire   +2 more sources

Diuretics and advanced features of nephroprotection

Počki, 2019
The most frequently used diuretics in nephrology, and the scheme and dosages used for their prescription are considered. Attention is focused on a new class of hypoglycemic drugs (gliflozins) that can provide nephroprotection to patients with diabetic nephropathy, and probably those with chronic kidney disease without diabetes mellitus type 2.
D.D. Ivanov, Lionel Rostaing
openaire   +1 more source

SGLT2 Inhibitors in Glomerulonephritis: Beyond Nephroprotection?

Journal of Clinical Medicine
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, initially developed for glycaemic control in type 2 diabetes, have demonstrated substantial renal and cardiovascular protective effects across various chronic kidney diseases (CKD), including glomerulonephritis.
Lucia Del Vecchio, Silvia Peiti, Giulio Pucci Bella, Francesco Locatelli   +3 more
openaire   +1 more source

Effect of Doum (<i>Hyphaene thebaica</i>) mesocarp and endosperm extracts on Triton X-100 induced hyperlipidemic rat: mitigative cardiovascular and renal dysfunction risks. [PDF]

Front Nutr
Almezail MS, Alhomaid RM.
europepmc   +1 more source